Sodium in PDB 7rma: Structure of the Fourth Uim (Ubiquitin Interacting Motif) of ANKRD13D in Complex with A High Affinity Ubv (Ubiquitin Variant)

The structure of Structure of the Fourth Uim (Ubiquitin Interacting Motif) of ANKRD13D in Complex with A High Affinity Ubv (Ubiquitin Variant), PDB code: 7rma was solved by A.U.Singer, N.Manczyk, G.Veggiani, F.Sicheri, S.S.Sidhu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	32.36 / 2.00
Space group	P 41 21 2
Cell size a, b, c (Å), α, β, γ (°)	45.77, 45.77, 84.39, 90, 90, 90
R / Rfree (%)	20.8 / 24.6

The binding sites of Sodium atom in the Structure of the Fourth Uim (Ubiquitin Interacting Motif) of ANKRD13D in Complex with A High Affinity Ubv (Ubiquitin Variant) (pdb code 7rma). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Structure of the Fourth Uim (Ubiquitin Interacting Motif) of ANKRD13D in Complex with A High Affinity Ubv (Ubiquitin Variant), PDB code: 7rma:

Sodium binding site 1 out of 1 in the Structure of the Fourth Uim (Ubiquitin Interacting Motif) of ANKRD13D in Complex with A High Affinity Ubv (Ubiquitin Variant)


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Structure of the Fourth Uim (Ubiquitin Interacting Motif) of ANKRD13D in Complex with A High Affinity Ubv (Ubiquitin Variant) within 5.0Å range: probe atom residue distance (Å) B Occ C:Na102 b:64.7 occ:1.00 O C:ARG13 3.8 27.8 1.0 CG C:GLN16 4.0 28.8 1.0 N C:LEU17 4.1 26.6 1.0 CB C:GLN16 4.1 25.2 1.0 CG C:ARG13 4.2 47.2 1.0 CA C:LEU17 4.3 30.6 1.0 CB C:LEU17 4.3 28.9 1.0 C C:GLN16 4.6 25.5 1.0 C C:ARG13 4.7 28.5 1.0 CD1 C:LEU17 4.9 35.5 1.0 CA C:ARG13 4.9 29.3 1.0

G.Veggiani, B.P.Yates, G.D.Martyn, N.Manczyk, A.U.Singer, I.Kurinov, F.Sicheri, S.S.Sidhu. Panel of Engineered Ubiquitin Variants Targeting the Family of Human Ubiquitin Interacting Motifs. Acs Chem.Biol. V. 17 941 2022.
ISSN: ESSN 1554-8937
PubMed: 35385646
DOI: 10.1021/ACSCHEMBIO.2C00089